Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Antibody combined with cancer drug shows promise against breast tumors
June 9th, 2005
An antibody that targets the blood vessels nourishing tumors significantly reduced breast cancer formation and growth in mice when combined with a current cancer drug. "This antibody could enhance the therapeutic efficacy of the drug docetaxel in breast cancer patients," said Philip Thorpe, professor of pharmacology at the University of Texas Southwestern Medical Center and senior author of the study, which was published in the May 15, 2005, issue of Cancer Research. "The combination merits further scrutiny as a potential treatment for human cancer." Docetaxel is one of the most effective chemotherapeutic drugs for treating breast, ovarian,...
Source: Women's Health Weekly (2005-06-09)
|
